Autoimmune myocarditis develops due to an immune response to cardiac-specific antigens expressed in the heart. The MHC is important in determining susceptibility to autoimmune myocarditis;however other genetic factors are also critical. We propose to study these genetic mechanisms using a mouse model, cardiac myosin-induced experimental autoimmune myocarditis (EAM). The goal of the present proposal is to further localize the genetic differences between susceptible and resistant mouse strains, and to distinguish the roles of several cell lineages in genetic susceptibility to autoimmune myocarditis. We will investigate two costimulatory candidate genes, ICOS (Specific aim 1) and CD27 (Specific aim 2). Both of these genes are located in susceptibility regions on chromosomes 1 and 6 respectively. Additionally, both ICOS and CD27 are differentially regulated following immunization with cardiac myosin in the susceptible and resistant mice.
Specific aim 1 will examine in depth our preliminary finding that resistant B 10.S mice have higher ICOS expression on CD4+T cells after myosin immunization. This finding suggests that at least part of the ICOS expressing CD4+ T cells are regulatory in EAM. Therefore we will assess the expression of ICOS on subsets of CD4+ T cells and determine the role of ICOS in effector and regulatory T cells during EAM by adoptively transferring ICOS deficient and/or IL-10 deficient CD4+ T cells into Rag-/- mice. We will also identify polymorphism in the ICOS gene.
Specific aim 2 CD27 is significantly down regulated in A.SW but not B10.S mice following immunization with cardiac myosin, suggesting that CD27 is a candidate gene influencing EAM susceptibility in the Eam2 region. We will first examine the CD27 gene for polymorphisms. Next, we will determine the kinetics and function of CD27 on T cells during EAM in A.SW and B10.S mice and test our hypothesis that down regulation of CD27 on T cells in early activation phase is essential for their differentiation to pathogenic effector cells. We have established that genetic control of EAM is mediated by cells of the hematopoietic lineage including T and/or B cells.
Specific aim 3 will examine if genetic factors modulate Th17 cells, NK cells, macrophages, B cells and T regulatory cells in mediating EAM. We will transfer bone marrow from cell specific knockout mice of the susceptible strain into the irradiated resistant strain. We have found that IL-23 production was less in B10.S mice than AS.W mice during EAM, which suggest that B10.S mice might be resistant to myocarditis due to their decrease and ability to induce differentiation or sustain survival of Th17 cells in heart. Therefore we will identify polymorphisms and the protein expression profile of cytokines and chemokines related to Th17 pathway following immunization with cardiac myosin in A.SW and B10.S mice.

Public Health Relevance

Myocarditis and subsequent dilated cardiomyopathy are major causes of heart failure, especially in young adults. By comparing strains of mice that are resistant or susceptible to myocarditis, we plan to identify genetic traits or early signals of susceptibility. These markers may help to design earlier treatments and avoid the need for heart transplantation

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
High Priority, Short Term Project Award (R56)
Project #
2R56HL077611-05
Application #
7924263
Study Section
Atherosclerosis and Inflammation of the Cardiovascular System Study Section (AICS)
Program Officer
Kaltman, Jonathan R
Project Start
2004-07-01
Project End
2012-08-31
Budget Start
2009-09-30
Budget End
2012-08-31
Support Year
5
Fiscal Year
2009
Total Cost
$369,000
Indirect Cost
Name
Johns Hopkins University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Rose, Noel R (2016) Viral myocarditis. Curr Opin Rheumatol 28:383-9
Abston, Eric D; Barin, Jobert G; Cihakova, Daniela et al. (2012) IL-33 independently induces eosinophilic pericarditis and cardiac dilation: ST2 improves cardiac function. Circ Heart Fail 5:366-75
Kaya, Ziya; Katus, Hugo A; Rose, Noel R (2010) Cardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure. Clin Immunol 134:80-8
Baldeviano, G Christian; Barin, Jobert G; Talor, Monica V et al. (2010) Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ Res 106:1646-55
Ligons, Davinna L; Guler, Mehmet L; Li, Haiyan S et al. (2009) A locus on chromosome 1 promotes susceptibility of experimental autoimmune myocarditis and lymphocyte cell death. Clin Immunol 130:74-82